These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21798605)

  • 1. Rise in international normalized ratio after a catastrophic earthquake in patients treated with warfarin.
    Oda M; Watanabe H; Oda E; Tomita M; Obata H; Ozawa T; Oda Y; Iizuka T; Toba K; Aizawa Y
    Int J Cardiol; 2011 Oct; 152(1):109-10. PubMed ID: 21798605
    [No Abstract]   [Full Text] [Related]  

  • 2. Unbalanced protein S deficiency due to warfarin treatment as a possible cause for thrombosis.
    Haran MZ; Lichman I; Berebbi A; Weinmann E; Rosenberg N
    Br J Haematol; 2007 Oct; 139(2):310-1. PubMed ID: 17897308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombosis in spite of warfarin--what should be done?].
    Lassila R
    Duodecim; 2001; 117(24):2632-6. PubMed ID: 12183826
    [No Abstract]   [Full Text] [Related]  

  • 4. International normalized ratio and anticoagulation.
    Theerman MR
    Arch Intern Med; 2003 May; 163(10):1242-3; author reply 1244. PubMed ID: 12767971
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulants to prevent stroke occurrence and worsening.
    Caplan LR
    Isr Med Assoc J; 2006 Nov; 8(11):773-8. PubMed ID: 17180829
    [No Abstract]   [Full Text] [Related]  

  • 6. [Levels of INR in patients admitted to the department of internal medicine].
    Flatau E; Reichman N; Kaufman N
    Harefuah; 2003 Feb; 142(2):97-9, 159. PubMed ID: 12653040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin sensitivity after mechanical heart valve replacement.
    Rose JP; Rihn TL; Long SF
    Pharmacotherapy; 1998; 18(4):856-9. PubMed ID: 9692661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of home testing of international normalized ratio on clinical events.
    Matchar DB; Jacobson A; Dolor R; Edson R; Uyeda L; Phibbs CS; Vertrees JE; Shih MC; Holodniy M; Lavori P;
    N Engl J Med; 2010 Oct; 363(17):1608-20. PubMed ID: 20961244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent warfarin potency inconsistencies compromise effectiveness.
    Rothschild BM
    Arch Intern Med; 2003 May; 163(10):1243; author reply 1244. PubMed ID: 12767972
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial.
    Woods K; Douketis JD; Schnurr T; Kinnon K; Powers P; Crowther MA
    Thromb Res; 2004; 114(3):161-5. PubMed ID: 15342212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Managing warfarin treatment in a small Icelandic rural practice in Húsavík].
    Kristinsson VH
    Laeknabladid; 2005 Sep; 91(9):657-60. PubMed ID: 16155336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
    Caine GJ; Lip GY
    Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
    Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
    Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use.
    Kim YD; Lee JH; Jung YH; Choi HY; Nam CM; Yang JH; Cho HJ; Nam HS; Lee KY; Heo JH
    J Neurol Sci; 2010 Nov; 298(1-2):101-5. PubMed ID: 20797733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
    Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.
    Sanfelippo MJ; Sennet J; McMahon EJ
    WMJ; 2000 Jun; 99(3):62-4, 43. PubMed ID: 10927985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical consequences of generic warfarin substitution: an ecological study.
    Paterson JM; Mamdani M; Juurlink DN; Naglie G; Laupacis A; Stukel TA
    JAMA; 2006 Oct; 296(16):1969-72. PubMed ID: 17062858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.